Lipid-engineered nanotherapeutics for cancer management
Cancer causes significant mortality and morbidity worldwide, but existing pharmacological treatments are greatly limited by the inherent heterogeneity of cancer as a disease, as well as the unsatisfactory efficacy and specificity of therapeutic drugs. Biopharmaceutical barriers such as low permeabil...
Saved in:
Main Authors: | Alicia Fernandez-Fernandez (Author), Romila Manchanda (Author), Manisha Kumari (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Smart Nanotherapeutics and Lung Cancer
by: Mohammad Doroudian, et al.
Published: (2021) -
The emerging potential of siRNA nanotherapeutics in treatment of arthritis
by: Anjali Kumari, et al.
Published: (2023) -
Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics
by: Rachna M. Kumar, et al.
Published: (2023) -
Nanotherapeutics to Overcome Conventional Cancer Chemotherapy Limitations
by: Moorthi Chidambaram, et al.
Published: (2011) -
Stimuli-Responsive Nanotherapeutics for Treatment and Diagnosis of Stroke
by: Manisha Choudhary, et al.
Published: (2023)